Weekly Research Analysts’ Ratings Changes for ACADIA Pharmaceuticals (ACAD)
Several brokerages have updated their recommendations and price targets on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) in the last few weeks: 8/5/2026 – ACADIA Pharmaceuticals had its price target raised by Royal Bank Of Canada from $36.00 to $37.00. They now have an “outperform” rating on the stock. 8/5/2026 – ACADIA Pharmaceuticals had its price […]
6 Aug 00:56 · The Markets Daily